Novabay Pharmaceuticals (NBY) Stock Price, Quote & News

Company Profile

NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 510 899 8800

Fax: 510 474 1577

Website: novabay.com

Address:

2000 Powell Street, Suite 1150, eleventh floor, Emeryville, United States

Duskfall Aug. 8 at 6:12 PM

$NBY 👍

0 · Reply

Bigdubs Aug. 8 at 5:32 PM

$NBY Lucid Cap. was a player in the SONN to Hyper Liquid merger: https://www.lucidcapitalmarkets.com/transactions Lucid Cap. is a known player here: https://s3.amazonaws.com/sec.irpass.cc/2807/0001437749-25-006555.htm Follow the breadcrumbs

0 · Reply

BullsofAmerica Aug. 1 at 1:06 PM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $TNON $RDDT $NBY $PSTV $DHAI

0 · Reply

Bigdubs Aug. 1 at 12:27 AM

$NBY about 1/2 of the outstanding warrants have now expired. Cap table is better now. Any good news 2m+ less shares can no longer be used.

1 · Reply

DrConnors Jul. 31 at 3:27 AM

$SPY $TSLA $NBY what kind of trash makes a post like this. People say im crazy when I tell them this is the type of trash thats out there and they call you a rat if you against child abuse. Typical satanist commie

3 · Reply

ABC123BCD Jul. 31 at 3:21 AM

$NBY $SPY $TSLA why would you talk about kids and porn movies unless you’re a pedophile? Please ban this weirdo

1 · Reply

ony2k Jul. 26 at 9:52 PM

$NBY In hindsight, It was during Christmas time five years ago I gave myself; let's say a rain check, if you will, on Avenola; not on that poser acting like a CEO. You know, the one that appeared fake AF while flying by the seat of his pants every time he opened that thing he continuously put his foot into, notwithstanding, the Dermadoctor aquisition likely intended for those two to get away with our money, from a bad idea and eventual failure to deliver what they were lying about. (to be contiued)

0 · Reply

Iiii1ii Jul. 26 at 8:50 AM

$NBY Next MCVT runner

0 · Reply

Duskfall Jul. 25 at 4:14 PM

$NBY 👍

0 · Reply

Bigdubs Jul. 22 at 11:06 PM

$NBY managed to grab some at .63 last week. Volume has dried up. Only 7 more trading days till the warrants expire.

1 · Reply

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Jan 23, 2025, 8:00 AM EST - 7 months ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Dec 19, 2024, 6:50 AM EST - 8 months ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 9, 2024, 6:50 AM EST - 8 months ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 22, 2024, 4:05 PM EST - 9 months ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 9 months ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 7, 2024, 4:05 PM EST - 9 months ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 9 months ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Oct 29, 2024, 8:00 AM EDT - 10 months ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Sep 20, 2024, 8:30 AM EDT - 11 months ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 11 months ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Aug 13, 2024, 11:29 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 16, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 11, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 7, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 11, 2024, 1:59 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 1 year ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 17, 2024, 6:59 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Mar 26, 2024, 6:43 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 11:43 PM EST - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Aug 12, 2023, 2:40 PM EDT - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results

Aug 8, 2023, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023

Jul 14, 2023, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Record Avenova Sales Day

Duskfall Aug. 8 at 6:12 PM

$NBY 👍

0 · Reply

Bigdubs Aug. 8 at 5:32 PM

0 · Reply

BullsofAmerica Aug. 1 at 1:06 PM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $TNON $RDDT $NBY $PSTV $DHAI

0 · Reply

Bigdubs Aug. 1 at 12:27 AM

$NBY about 1/2 of the outstanding warrants have now expired. Cap table is better now. Any good news 2m+ less shares can no longer be used.

1 · Reply

DrConnors Jul. 31 at 3:27 AM

3 · Reply

ABC123BCD Jul. 31 at 3:21 AM

$NBY $SPY $TSLA why would you talk about kids and porn movies unless you’re a pedophile? Please ban this weirdo

1 · Reply

ony2k Jul. 26 at 9:52 PM

0 · Reply

Iiii1ii Jul. 26 at 8:50 AM

$NBY Next MCVT runner

0 · Reply

Duskfall Jul. 25 at 4:14 PM

$NBY 👍

0 · Reply

Bigdubs Jul. 22 at 11:06 PM

$NBY managed to grab some at .63 last week. Volume has dried up. Only 7 more trading days till the warrants expire.

1 · Reply

Duskfall Jul. 21 at 4:21 PM

$NBY Extremely

1 · Reply

Duskfall Jul. 18 at 2:38 PM

$ECDA hmm.. Okay it looks like it's going down.. But you know what? I took $NBY today looks like a good swing. Any news and it explode 💥

0 · Reply

BETHETHUNDER Jul. 18 at 8:57 AM

$NBY

0 · Reply

Stock_Catcher Jul. 18 at 2:48 AM

Money Friday Watchlist Pt. 8 $EVAX $NBY $SMX $SBFM $WLGS Let's Finish This Week STRONG team

0 · Reply

Bigdubs Jul. 15 at 6:11 PM

$NBY come dip under those warrants of .66… I wanna add a few more 😋

1 · Reply

Mrmessiah Jul. 15 at 12:48 AM

$NBY if we instead decide to pursue an alternative strategic transaction, then we expect that as part of such transaction that we will continue working to regain NYSE American compliance.” That strongly suggests they are shopping for a buyer or looking to be used as a shell for a reverse merger, while keeping the door open for relisting if the deal is significant enough. ✅ 1. Business Is Winding Down “Our business was significantly reduced.” “…completed the Avenova Asset Divestiture and the Wound Care Divestiture…” That confirms NovaBay has divested its core assets, leaving it closer to a shell structure — ideal for a reverse merger ✅ 2. Still Exploring Strategic Alternatives “…the Company is continuing to explore other potential strategic This is a textbook setup for a reverse merger or SPAC-like transaction, minus the formal SPAC structure.

0 · Reply

Mrmessiah Jul. 15 at 12:45 AM

$NBY Seems like a lock for a reverse merger . Only concern is that they are in no rush with enough cash to find them through mid 2026.

1 · Reply

Mrmessiah Jul. 14 at 11:48 PM

$NBY Who is still sitting g on this one?

1 · Reply

AsianAmericanPsycho Jul. 14 at 4:32 PM

$NBY Thoughts on this fair value and why? lol 😂 “ You Son of a Bitch, I’m in!”

1 · Reply

Squirrely_McShitty Jul. 14 at 2:39 PM

$NBY

0 · Reply

emw3000 Jul. 14 at 2:26 PM

$NBY

0 · Reply

Bigdubs Jul. 14 at 12:49 PM

$NBY like I said before great shell pick and hoping for a SPA. Would be extremely surprised if this continues to run over .66 with a large batch of warrants exp. July 31… you know those wanna convert. My hopeful timeline for a SPA is in Aug on that fact alone. What company it would be is anyone’s guess. EYEN (HYPD) did crypto and I’m still blown away at that one.

0 · Reply

Market Cap	3.45M
Revenue (ttm)	9.78M
Net Income (ttm)	-7.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-73.82%
Debt to Equity Ratio	-3.85

Volume	8,031
Avg Vol	36,246
Day's Range	N/A - N/A
Shares Out	5.82M
Stochastic %K	24%
Beta	0.40
Analysts	Sell
Price Target	$0.85